In August 2022,
President Biden signed the Inflation Reduction Act into law lowering prescription drug costs for those on Medicare.
Below are the 10 selected Part D medications and their newly negotiated prices effective January 1,2026.
Timeline:
| Drug | Used for | Original Listed Price | IRA New Negotiated Price |
|---|---|---|---|
| Eliquis | Anticoagulant | $521 | $231 |
| Jardiance | Type 2 diabetes, heart failure | $573 | $197 |
| Xarelto | Anticoagulant | $517 | $197 |
| Januvia | Type 2 diabetes | $527 | $113 |
| Farxiga | Diabetes, heart failure, chronic kidney disease | $556 | $178.50 |
| Entresto | Heart failure | $628 | $295 |
| Enbrel | Rheumatoid arthritis | $7,106 | $2,355 |
| Imbruvica | Leukemia, lymphoma | $14,934 | $9,319 |
| Stelara | Psoriasis, psoriatic arthritis, Crohn’s disease, ulcerative colitis | $13,836 | $4,695 |
| Fiasp | Diabetes | $495 | $119 |
